« Previous
Next »
Titles
- ANDA submissions: amendments and requests for final approval to tentatively approved ANDAs1
- Alternative procedures for blood and blood components during the COVID-19 public health emergency1
- Assessing COVID-19-related symptoms in outpatient adult and adolescent subjects in clinical trials of drugs and biological products for COVID-19 prevention or treatment1
- Assessing user fees under the Biosimilar User Fee Amendments of 20171